IQ-AI, Ltd.

IQ-AI, Ltd.

  • News & Announcements
  • Shareholder Information
  • Investor Relations
  • Significant Shareholders
  • Publications
  • Home
  • Corporate News & Announcements
  • IQ-AI News & Announcements
  • Board Changes
 

BLOG

IQ-AI
Thursday, 02 September 2021 / Published in IQ-AI News & Announcements

Board Changes

/**/
RNS Number : 4651K
IQ-AI Limited
02 September 2021
 

2 September 2021

IQ-AI Limited

(“IQ-AI” or the “Company”)

 

Board Changes

 

IQ-AI Limited (LSE: IQAI; OTCQB: IQAIF) announces that Brett Skelly has been appointed as a non-executive Director of the Company with immediate effect.

 

Brett has been working in the financial sector for GBAC Limited for over 16 years, carrying out various roles, including preparing accounts and auditing a wide range of large and SME companies, as well as preparing management information and forecasts. He has been involved in developing business plans and also been involved in a number of company sales and MBO’s over the years.

 

In December 2017, Brett became the outsourced financial controller of AIM listed Braveheart Investment Group Plc and is also the outsourced financial controller at Anticus Partners Limited.

 

IQ-AI also announces that Qu Li has resigned as a non-executive Director of the Company to pursue her other business interests. The Directors of the Company would like to thank Qu Li for her contribution to the Company’s recent development.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

IQ-AI Limited

Trevor Brown/Brett Skelly/Vinod Kaushal

 

0207 469 0930

 

Peterhouse Capital Limited

Lucy Williams/Heena Karani

 

0207 220 9797

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Article source
  • Tweet

What you can read next

Notice of AGM
StoneChecker still on track for FDA clearance and commercial roll out of software
IQ-AI files patent for non-toxic MRI scan technology

Recent Posts

  • IQ-AI shares cease trading on the OTCQB

    /**/ RNS Number : 9599M IQ-AI Limited 19 Septem...
  • Reduced Gadolinium Approach Validated’

    /**/ RNS Number : 7871L IQ-AI Limited 08 Septem...
  • Update on Collaboration Agreement with Mayo Clinic

    /**/ RNS Number : 8096J IQ-AI Limited 18 August...
  • IB & GE HealthCare Enter into Commercial Agreement

    /**/ RNS Number : 8077J IQ-AI Limited 18 August...
  • Half-year Report

    /**/ RNS Number : 5460J IQ-AI Limited 17 August...
  • Policies
  • Investor Information

iq-ai@imagingbiometrics.com

P. O. Box 264
Forum 4, Grenville Street
St Helier, Jersey, Channel Islands
JE4 8TQ

Copyright © 2015-2023 IQ-AI. All Rights Reserved
TOP
Our website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptReject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT